Legend Biotech Corporation Aktie
WKN DE: A2P5AH / ISIN: US52490G1022
18.08.2025 16:43:59
|
Legend Biotech Names Carlos Santos CFO
(RTTNews) - Legend Biotech Corp. (LEGN), Monday announced the appointment of Carlos Santos as the company's Chief Financial Officer, effective immediately.
Santos will succeed Jessie Yeung, who has served as the interim CFO since January 2025.
Prior to joining Legend Biotech, Santos was CFO for U.S. Oncology at AstraZeneca.
""Legend has established itself as a leader in cell therapy innovation, and I look forward to working alongside this talented executive team to continue building on the Company's strong foundation," Santos commented.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Legend Biotech Corporation (spons. ADRs)mehr Nachrichten
10.08.25 |
Ausblick: Legend Biotech stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) | |
12.05.25 |
Ausblick: Legend Biotech stellt Quartalsergebnis zum abgelaufenen Jahresviertel vor (finanzen.net) |
Analysen zu Legend Biotech Corporation (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Legend Biotech Corporation (spons. ADRs) | 28,00 | 0,72% |
|